BIOMAT Database Logo BIOMAT Database Logo

Effects of combination therapy with an angiotensin converting enzyme inhibitor and thiazide diuretic on insulin action in essential hypertension. 1998

S J Hunter, and R Harper, and C N Ennis, and E Crothers, and B Sheridan, and G D Johnston, and A B Atkinson, and P M Bell
Metabolic Unit, Royal Victoria Hospital, Belfast, UK.

OBJECTIVE To determine whether combination of an angiotensin converting enzyme inhibitor with a high dose of thiazide diuretic avoids adverse metabolic consequences of thiazide diuretics. METHODS Double-blind randomized crossover study of two 12-week treatment periods with captopril (up to 100 mg/day) either alone or in combination with 5 mg bendrofluazide given after a 6-week placebo run-in period. Treatment periods were separated by a 6-week placebo washout period. METHODS Outpatient clinics in greater Belfast. METHODS Fifteen white non-diabetic essential hypertensives (seven male) aged < 65 years recruited from general practices in greater Belfast. METHODS Systolic and diastolic blood pressures and peripheral and hepatic insulin action. RESULTS Two patients failed to complete the study. Blood pressure was lowered (139/89+/-18/7 mmHg combination versus 160/97+/-21/7 mmHg captopril; P < 0.001). Fasting insulin level was raised (7.9+/-3.6 mU/l combination versus 6.2+/-3.2 mU/l baseline; P < 0.001). There were no differences between treatments for glucose, urate, cholesterol and triglyceride levels. Serum potassium level was lowered (3.8+/-0.4 mmol/l combination versus 4.2+/-0.4 mmol/l captopril, P < 0.05). Postabsorptive endogenous glucose production was raised (10.8+/-1.7 micromol/kg per min combination versus 10.0+/-1.5 micromol/kg per min captopril; P < 0.01) and was greater than baseline (9.7+/-2.1 micromol/kg per min, P < 0.05). Suppression of glucose production by insulin was similar with both treatments. Exogenous glucose infusion rates required to maintain euglycaemia did not differ (32.4+/-7.6 micromol/kg per min captopril, 32.7+/-6.2 micromol/kg per min combination, 31.5+/-7.2 micromol/kg per min baseline). CONCLUSIONS Combination therapy increased glucose production (compared with captopril alone), indicating hepatic insulin resistance. It cannot be assumed that combined preparations with angiotensin converting enzyme inhibitors will ameliorate adverse effects of high doses of thiazide diuretics on insulin action.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002216 Captopril A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin. (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline,Capoten,Lopirin,SQ-14,225,SQ-14,534,SQ-14225,SQ-14534,SQ 14,225,SQ 14,534,SQ 14225,SQ 14534,SQ14,225,SQ14,534,SQ14225,SQ14534
D004232 Diuretics Agents that promote the excretion of urine through their effects on kidney function. Diuretic,Diuretic Effect,Diuretic Effects,Effect, Diuretic,Effects, Diuretic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug

Related Publications

S J Hunter, and R Harper, and C N Ennis, and E Crothers, and B Sheridan, and G D Johnston, and A B Atkinson, and P M Bell
Effects on insulin action of adding low-dose thiazide to angiotensin-converting enzyme inhibitor in essential hypertension.
April 2013, Hypertension (Dallas, Tex. : 1979),
S J Hunter, and R Harper, and C N Ennis, and E Crothers, and B Sheridan, and G D Johnston, and A B Atkinson, and P M Bell
Combination therapy with an angiotensin converting enzyme inhibitor and an angiotensin-II receptor antagonist for refractory essential hypertension.
April 1998, The Western journal of medicine,
S J Hunter, and R Harper, and C N Ennis, and E Crothers, and B Sheridan, and G D Johnston, and A B Atkinson, and P M Bell
Influence of an angiotensin converting-enzyme inhibitor on diuretic-induced metabolic effects in hypertension.
January 1983, Hypertension (Dallas, Tex. : 1979),
S J Hunter, and R Harper, and C N Ennis, and E Crothers, and B Sheridan, and G D Johnston, and A B Atkinson, and P M Bell
Moderate sodium restriction, angiotensin converting enzyme inhibition, and thiazide diuretic in the management of essential hypertension.
January 1989, Journal of cardiovascular pharmacology,
S J Hunter, and R Harper, and C N Ennis, and E Crothers, and B Sheridan, and G D Johnston, and A B Atkinson, and P M Bell
Effects of low dose versus conventional dose thiazide diuretic on insulin action in essential hypertension.
July 1994, BMJ (Clinical research ed.),
S J Hunter, and R Harper, and C N Ennis, and E Crothers, and B Sheridan, and G D Johnston, and A B Atkinson, and P M Bell
Control of essential hypertension with captopril, an angiotensin converting enzyme inhibitor.
May 1981, British journal of clinical pharmacology,
S J Hunter, and R Harper, and C N Ennis, and E Crothers, and B Sheridan, and G D Johnston, and A B Atkinson, and P M Bell
Glucose tolerance and insulin secretion in essential hypertension after treatment with an angiotensin converting enzyme inhibitor.
December 1991, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
S J Hunter, and R Harper, and C N Ennis, and E Crothers, and B Sheridan, and G D Johnston, and A B Atkinson, and P M Bell
Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.
February 2007, Hypertension (Dallas, Tex. : 1979),
S J Hunter, and R Harper, and C N Ennis, and E Crothers, and B Sheridan, and G D Johnston, and A B Atkinson, and P M Bell
Effects of the angiotensin converting enzyme inhibitor, captopril, in essential hypertension.
February 1982, British journal of clinical pharmacology,
S J Hunter, and R Harper, and C N Ennis, and E Crothers, and B Sheridan, and G D Johnston, and A B Atkinson, and P M Bell
Comparison of effects of low dose of spironolactone and a thiazide diuretic in patients with hypertension treated with an angiotensin-converting enzyme inhibitor or an angiotensin type 1 receptor blocker.
November 2009, Clinical and experimental hypertension (New York, N.Y. : 1993),
Copied contents to your clipboard!